Ronald Rogers News
-
Inside Reindert Dooves’s home, a 17th- century, three-story converted warehouse along the Zaan canal in suburban Amsterdam, a 21st-century Internet giant is avoiding taxes.
-
Merck & Co., the second-largest U.S. drugmaker, received a subpoena from the Department of Justice related to the sales of three cancer and viral drugs.
-
The U.K. needs to build closer ties with China’s central bank to unleash London’s potential market in offshore yuan trading, according to a former adviser to the People’s Bank of China.
-
Merck & Co. failed to win U.S. approval of an oral contraceptive already sold in Europe and a glaucoma treatment on the market in nine countries.
-
Merck & Co. agreed to let Glenmark Pharmaceuticals Ltd. sell a generic version of the cholesterol medicine Zetia in the U.S. by December 2016 as part of a settlement of a patent-infringement lawsuit.
-
Pfizer Inc. Chief Executive Officer Ian Read said his company, the world’s biggest drugmaker, will fight attempts to cut Medicare payments for medicines after the industry helped underwrite the U.S. health-care overhaul.
-
Harris Corp. a maker of communications-related electronic equipment, sued Netgear Inc. for allegedly infringing network-security patents.
-
Achillion Pharmaceuticals Inc., the developer of hepatitis C treatments that was passed over by potential acquirers in the last year, is poised to draw renewed interest after setbacks by rival drugmakers.
-
HSBC Holdings Plc settled a lawsuit brought by a group of Taiwanese banks that accused HSBC Bank USA of helping deceased financier Danny Pang’s PEMGroup defraud them of more than $500 million.
-
Former Marvell Technology Group Ltd. accountant Stanley Ng was charged with conspiracy by U.S. prosecutors as part of a nationwide probe of insider trading involving so-called expert networking firms.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page